Roubaix Capital’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-89,856
Closed -$2.18M 70
2024
Q4
$2.18M Buy
89,856
+8,742
+11% +$250K 1.05% 43
2024
Q3
$3.01M Sell
81,114
-9,058
-10% -$338K 1.66% 30
2024
Q2
$4.29M Buy
+90,172
New +$3.95M 2.71% 11
2023
Q1
Sell
-56,756
Closed -$2.75M 57
2022
Q4
$2.75M Buy
+56,756
New +$3.56M 2.23% 18
2022
Q3
Sell
-77,472
Closed -$5.5M 53
2022
Q2
$5.5M Buy
77,472
+6,338
+9% +$408K 4.73% 2
2022
Q1
$5.68M Buy
+71,134
New +$5.3M 3.92% 6
2020
Q4
Sell
-28,512
Closed -$1.61M 67
2020
Q3
$1.61M Sell
28,512
-6,666
-19% -$359K 1.9% 24
2020
Q2
$2.17M Sell
35,178
-3,467
-9% -$142K 2.88% 7
2020
Q1
$1.25M Buy
+38,645
New +$1.3M 1.89% 22
2019
Q3
Sell
-87,004
Closed -$2.56M 46
2019
Q2
$2.56M Buy
+87,004
New +$2.51M 2.13% 26

Other funds holding STAA

Roubaix Capital's STAA Position: Q1 2025 in Review

Roubaix Capital sold out of STAAR Surgical (STAA) in Q1 2025, closing a stake of 89,856 shares — an estimated $2.18M sold.

Roubaix Capital first reported a position in STAA in Q2 2019 and held it in 10 quarters. The position peaked at $5.68M in Q1 2022. 185 funds tracked by Wall St. Rank hold STAA as of Q1 2025.

  • Roubaix Capital reported no remaining STAAR Surgical position as of Q1 2025 after selling out during the quarter.
  • Roubaix Capital sold 89,856 STAAR Surgical shares in Q1 2025, an estimated $2.18M.
  • Roubaix Capital first reported a position in STAAR Surgical in Q2 2019 and held it in 10 quarters.
  • Roubaix Capital's STAAR Surgical position peaked at $5.68M in Q1 2022.
  • 185 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2025.

Based on Roubaix Capital's 13F filing for Q1 2025, filed 13 May 2025.